Rifampicin ($RIF) Price Prediction 2025–2030
Discover Rifampicin ($RIF) price forecasts for 2025. Get insights into long-term predictions up to 2026-2030
Discover Rifampicin ($RIF) price forecasts for 2025. Get insights into long-term predictions up to 2026-2030
Discover the current and predicted price of Rifampicin ($RIF). Analyze important metrics such as green days and 50-day SMA to assess market sentiment.
50-day SMA The 50-day SMA is the average closing price of $RIF over the past 50 days, used to assess trends. $0 | 200-day SMA The 200-day SMA is the average closing price of $RIF over the past 200 days. Its a key indicator used to identify long-term price trends. $0 | Volatility Volatility measures the price fluctuation of $RIF over the last 30 days. Higher volatility indicates greater price swings and potentially higher risk. 59.97 | Down Days Down Days represent the number of days in the past 30 where the closing price of $RIF was lower than its opening price, indicating negative price movement. 15 | Green Days Green Days are the days when $RIF closed higher than it opened, indicating positive price movement. 15 |
Discover short-term price predictions for Rifampicin ($RIF). Check forecasted prices for today, tomorrow, and the next 30 days to guide your trading strategy.
Date | High | Low | End | Potential ROI |
---|---|---|---|---|
2025-08-10 | $0.002003 | $0.001985 | $0.002003 | -21.05 % |
2025-08-11 | $0.002050 | $0.001985 | $0.002050 | -19.17 % |
2025-08-10 | $0.002003 | $0.001985 | $0.002003 | -21.05 % |
2025-08-31 | $0.002233 | $0.001985 | $0.002199 | -11.91 % |
Discover short-term price targets for Rifampicin ($RIF), with predictions for each day in the next 30 days. Potential ROI is provided for every target.
Date | Price | Potential ROI |
---|---|---|
2025-08-09 | $0.001985 | -21.7 % |
2025-08-10 | $0.002003 | -21.05 % |
2025-08-11 | $0.002050 | -19.17 % |
2025-08-12 | $0.002034 | -19.76 % |
2025-08-13 | $0.002067 | -18.47 % |
2025-08-14 | $0.002043 | -19.44 % |
2025-08-15 | $0.002077 | -18.08 % |
2025-08-16 | $0.002138 | -15.73 % |
2025-08-17 | $0.002165 | -14.6 % |
2025-08-18 | $0.002197 | -13.34 % |
2025-08-19 | $0.002191 | -13.57 % |
2025-08-20 | $0.002139 | -15.64 % |
2025-08-21 | $0.002144 | -15.49 % |
2025-08-22 | $0.002181 | -14.01 % |
2025-08-23 | $0.002170 | -14.44 % |
2025-08-24 | $0.002173 | -14.35 % |
2025-08-25 | $0.002126 | -16.14 % |
2025-08-26 | $0.002115 | -16.58 % |
2025-08-27 | $0.002233 | -11.91 % |
2025-08-28 | $0.002151 | -15.18 % |
2025-08-29 | $0.002138 | -15.67 % |
2025-08-30 | $0.002138 | -15.67 % |
2025-08-31 | $0.002199 | -13.32 % |
2025-09-01 | $0.002224 | -12.3 % |
2025-09-02 | $0.002164 | -14.66 % |
2025-09-03 | $0.002148 | -15.31 % |
2025-09-04 | $0.002227 | -12.17 % |
2025-09-05 | $0.002288 | -9.79 % |
2025-09-06 | $0.002268 | -10.59 % |
2025-09-07 | $0.002230 | -12.1 % |
2025-09-08 | $0.002243 | -11.58 % |
Discover long-term price forecasts for Rifampicin ($RIF) for 2026-2030. Future prices and potential ROI are estimated year-by-year to help guide your investment strategy.
Year | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
2025 | $0.002634 | $0.001985 | $0.002341 | 3.82 % |
2026 | $0.003001 | $0.001850 | $0.002448 | 18.33 % |
2027 | $0.002846 | $0.001889 | $0.002309 | 12.2 % |
2028 | $0.003018 | $0.001975 | $0.002469 | 19.02 % |
2029 | $0.003178 | $0.002085 | $0.002576 | 25.31 % |
2030 | $0.002867 | $0.002109 | $0.002455 | 13.03 % |
2031 | $0.002677 | $0.002340 | $0.002533 | 5.58 % |
For 2025, Rifampicin ($RIF) is forecasted to range between $0.001986 and $0.002634. December could be the most bullish month, with potential growth of 3.82.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
August | $5.58 | $5.58 | $5.58 | 5.58 % |
September | $5.58 | $5.58 | $5.58 | 5.58 % |
October | $5.58 | $5.58 | $5.58 | 5.58 % |
November | $5.58 | $5.58 | $5.58 | 5.58 % |
December | $5.58 | $5.58 | $5.58 | 5.58 % |
For 2026, Rifampicin ($RIF) is forecasted to range between $0.001850 and $0.003002. December could be the most bullish month, with potential growth of 18.33.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $5.58 | $5.58 | $5.58 | 5.58 % |
February | $5.58 | $5.58 | $5.58 | 5.58 % |
March | $5.58 | $5.58 | $5.58 | 5.58 % |
April | $5.58 | $5.58 | $5.58 | 5.58 % |
May | $5.58 | $5.58 | $5.58 | 5.58 % |
June | $5.58 | $5.58 | $5.58 | 5.58 % |
July | $5.58 | $5.58 | $5.58 | 5.58 % |
August | $5.58 | $5.58 | $5.58 | 5.58 % |
September | $5.58 | $5.58 | $5.58 | 5.58 % |
October | $5.58 | $5.58 | $5.58 | 5.58 % |
November | $5.58 | $5.58 | $5.58 | 5.58 % |
December | $5.58 | $5.58 | $5.58 | 5.58 % |
For 2027, Rifampicin ($RIF) is forecasted to range between $0.001889 and $0.002846. December could be the most bullish month, with potential growth of 12.2.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $5.58 | $5.58 | $5.58 | 5.58 % |
February | $5.58 | $5.58 | $5.58 | 5.58 % |
March | $5.58 | $5.58 | $5.58 | 5.58 % |
April | $5.58 | $5.58 | $5.58 | 5.58 % |
May | $5.58 | $5.58 | $5.58 | 5.58 % |
June | $5.58 | $5.58 | $5.58 | 5.58 % |
July | $5.58 | $5.58 | $5.58 | 5.58 % |
August | $5.58 | $5.58 | $5.58 | 5.58 % |
September | $5.58 | $5.58 | $5.58 | 5.58 % |
October | $5.58 | $5.58 | $5.58 | 5.58 % |
November | $5.58 | $5.58 | $5.58 | 5.58 % |
December | $5.58 | $5.58 | $5.58 | 5.58 % |
For 2028, Rifampicin ($RIF) is forecasted to range between $0.001976 and $0.003019. December could be the most bullish month, with potential growth of 19.02.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $5.58 | $5.58 | $5.58 | 5.58 % |
February | $5.58 | $5.58 | $5.58 | 5.58 % |
March | $5.58 | $5.58 | $5.58 | 5.58 % |
April | $5.58 | $5.58 | $5.58 | 5.58 % |
May | $5.58 | $5.58 | $5.58 | 5.58 % |
June | $5.58 | $5.58 | $5.58 | 5.58 % |
July | $5.58 | $5.58 | $5.58 | 5.58 % |
August | $5.58 | $5.58 | $5.58 | 5.58 % |
September | $5.58 | $5.58 | $5.58 | 5.58 % |
October | $5.58 | $5.58 | $5.58 | 5.58 % |
November | $5.58 | $5.58 | $5.58 | 5.58 % |
December | $5.58 | $5.58 | $5.58 | 5.58 % |
For 2029, Rifampicin ($RIF) is forecasted to range between $0.002085 and $0.003179. December could be the most bullish month, with potential growth of 25.31.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $5.58 | $5.58 | $5.58 | 5.58 % |
February | $5.58 | $5.58 | $5.58 | 5.58 % |
March | $5.58 | $5.58 | $5.58 | 5.58 % |
April | $5.58 | $5.58 | $5.58 | 5.58 % |
May | $5.58 | $5.58 | $5.58 | 5.58 % |
June | $5.58 | $5.58 | $5.58 | 5.58 % |
July | $5.58 | $5.58 | $5.58 | 5.58 % |
August | $5.58 | $5.58 | $5.58 | 5.58 % |
September | $5.58 | $5.58 | $5.58 | 5.58 % |
October | $5.58 | $5.58 | $5.58 | 5.58 % |
November | $5.58 | $5.58 | $5.58 | 5.58 % |
December | $5.58 | $5.58 | $5.58 | 5.58 % |
For 2030, Rifampicin ($RIF) is forecasted to range between $0.002109 and $0.002867. December could be the most bullish month, with potential growth of 13.03.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $5.58 | $5.58 | $5.58 | 5.58 % |
February | $5.58 | $5.58 | $5.58 | 5.58 % |
March | $5.58 | $5.58 | $5.58 | 5.58 % |
April | $5.58 | $5.58 | $5.58 | 5.58 % |
May | $5.58 | $5.58 | $5.58 | 5.58 % |
June | $5.58 | $5.58 | $5.58 | 5.58 % |
July | $5.58 | $5.58 | $5.58 | 5.58 % |
August | $5.58 | $5.58 | $5.58 | 5.58 % |
September | $5.58 | $5.58 | $5.58 | 5.58 % |
October | $5.58 | $5.58 | $5.58 | 5.58 % |
November | $5.58 | $5.58 | $5.58 | 5.58 % |
December | $5.58 | $5.58 | $5.58 | 5.58 % |
For 2031, Rifampicin ($RIF) is forecasted to range between $0.002340 and $0.002678. December could be the most bullish month, with potential growth of 5.58.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $5.58 | $5.58 | $5.58 | 5.58 % |